Ingevity (NGVT) Operating Expenses (2015 - 2026)

Ingevity (NGVT) has 12 years of Operating Expenses data on file, last reported at $47.9 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $47.9 million, down 5.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $202.7 million (up 12.55% YoY), and the FY2025 annual result was $212.4 million, up 16.32% from the prior year.
• Operating Expenses fell to $47.9 million in Q1 2026 per NGVT's latest filing, from $51.7 million in the prior quarter.
• Over five years, Operating Expenses peaked at $116.8 million in Q1 2024 and troughed at $26.3 million in Q4 2023.
• A 5-year average of $57.6 million and a median of $51.7 million in 2025 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 60.27% in 2023, then surged 96.96% in 2024.
• A 5-year view of Operating Expenses shows it stood at $66.2 million in 2022, then plunged by 60.27% to $26.3 million in 2023, then jumped by 39.92% to $36.8 million in 2024, then surged by 40.49% to $51.7 million in 2025, then retreated by 7.35% to $47.9 million in 2026.
• Business Quant data shows NGVT's Operating Expenses at $47.9 million in Q1 2026, $51.7 million in Q4 2025, and $51.1 million in Q3 2025.